<< Human dummy to teach medics | High rates of cervical cancer are indicators of larger problems in access to health care >>
Read in | English | Español | Français | Deutsch | Português | Italiano | 日本語 | 한국어 | 简体中文 | 繁體中文 | Nederlands | Bahasa | Norsk | Русский | Svenska | Polski

Fertility boost for testicular cancer patients

Published on July 21, 2005 at 5:33 AM · No Comments

The vast majority of men who try to have a family, following treatment for testicular cancer, are able to father children - according to a report published today in the British Journal of Cancer.

Scientists at The Institute of Cancer Research and The Royal Marsden NHS Foundation Trust studied almost 700 patients who had been treated for testicular cancer between 1982 and 1992 and asked them to complete a questionnaire relating to fertility and general health.

Just over 200 men reported attempting conception and 159 of these (77 per cent) succeeded in becoming fathers. A further 10 patients fathered children after fertility treatment.

The study also found that patients treated with chemotherapy after surgery had an increased risk of infertility compared to those who had no follow-up treatment or had radiotherapy only. But it was less than had been expected.

Among the men attempting conception without fertility treatment, those who had had surgery but no further treatment had the highest rate of success (85 per cent); those who had radiotherapy achieved an 82 per cent success rate; those who had chemotherapy achieved a 71 per cent success rate and those who were given both chemotherapy and radiotherapy had a 67 per cent success rate.

Lead scientist Dr Robert Huddart of The Institute of Cancer Research and The Royal Marsden NHS Foundation Trust, says: “Our previous studies suggested that most men’s sperm counts recover after chemotherapy. In this study we have shown that after treatment with chemotherapy or radiotherapy the majority of men who want to father children can do so.”

“In patients who had no treatment after surgery we found that 15 per cent had difficulty conceiving; treatment made this percentage slightly higher but not dramatically so. More than 70 per cent of patients who had chemotherapy were still fertile.

“It is important that patients should be monitored for testosterone as low levels of this hormone affect quality of life and men with less testosterone tend to be less sexually active.”

Patients were also invited to answer questions about sexual function and satisfaction. Most men answered this and of those more than 83 per cent said they had a satisfying sexual relationship with their partner.

Comments
The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News-Medical.Net.



  Country flag

biuquote
  • Comment
  • Preview
Loading